<DOC>
	<DOCNO>NCT00761228</DOCNO>
	<brief_summary>The purpose study test drug apomorphine subject Vegetative State Minimally Conscious State .</brief_summary>
	<brief_title>Efficacy Study NH001 Vegetative State &amp; Minimally Conscious State Following Traumatic Brain Injury</brief_title>
	<detailed_description>This prospective , multi-center , randomize , double-blind , placebo-controlled study safety efficacy NH001 improve functional outcome patient vegetative state minimally conscious state follow severe traumatic brain injury ( TBI ) .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Persistent Vegetative State</mesh_term>
	<mesh_term>Apomorphine</mesh_term>
	<criteria>1 . Patient 18 50 year age , inclusive . 2 . Male nonpregnant female ( female childbearing potential require undergone pregnancy test negative result prior entry study ) . 3 . Patients sustain severe close head injury within one four month . 4 . Patients remain vegetative minimally conscious state one four month injury . 5 . Patients reach stabilized clinical state prior admission study ( e.g . afebrile , haemodynamic electrolyte stability ) . 6 . Patients mean DRS score 17 29 , measure twice day two consecutive day . 7 . Informed consent legal representative obtain , accord procedure outline Section 8.1.2 . 8 . Patients , accord investigator 's opinion , likely available require 180day follow evaluation . 1 . Patients clinically stable time entry study ( infection , cardiovascular decompensation , etc . ) 2 . Patients require mechanical respiratory assistance . 3 . Patients show sign progressive neurological deterioration postTBI . 4 . Patients known history medically relevant substance abuse . 5 . Patients history cardiac disease . 6 . Patients suffer anoxic event . 7 . Patients receive investigational drug within 30 day study . 8 . Patients previously use NH001 , dopaminergic agent ( e.g . levodopa , amantadine , domperidone ) know neurostimulant ( e.g . methylphenidate , amphetamine , atomoxetine , modafinil ) within last 7 day day . 9 . Patients receive dopamine blocker ( e.g . risperidone , haloperidol , chlorpromazine , flupenthixol , clozapine , olanzapine , quetiapine ) 10 . Patients receive drug 5HT3 antagonist class , include , example , ondansetron , granisetron , dolasetron , palonosetron alosetron . 11 . Patients receive tricyclic antidepressant drug 12 . Patients receive type I antiarrhythmics ( i.e . quinidine ) . 13 . Patients known history cardiac arrhythmia congenital QTc prolongation . 14 . Patients know history previous neurological functional impairment ( e.g . stroke , spinal cord injury , dementia , epilepsy , psychiatric disease ) . 15 . Patients experience seizure within first week post injury ongoing seizure . 16 . Patients receive prophylactic anticonvulsive medication . 17 . Patients known allergy apomorphine , morphine , sulfites trimethobenzamide . 18 . Patients receive nitrate vasodilator . 19 . Patients receive CNS act agent barbiturate , morphine , belladonna , opiates . 20 . For male patient , patient receive trazodone drug know produce priapism . 21 . Patients without relative legal guardian consent study . 22 . Patients , accord investigator 's opinion , unlikely available require 180day follow evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Vegetative State</keyword>
	<keyword>Minimally Conscious State</keyword>
	<keyword>Coma</keyword>
	<keyword>Traumatic Brain Injury</keyword>
</DOC>